Home/Filings/4/0001567619-19-002514
4//SEC Filing

Fairhurst David Ogden 4

Accession 0001567619-19-002514

CIK 0000063908other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 3:07 PM ET

Size

34.9 KB

Accession

0001567619-19-002514

Insider Transaction Report

Form 4
Period: 2019-02-05
Fairhurst David Ogden
EVP & Chief People Officer
Transactions
  • Sale

    Common Stock

    2019-02-05$178.25/sh76,411$13,620,2613,148 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$63.25/sh+8,962$566,84712,110 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$94.89/sh+8,695$825,06946,878 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$116.73/sh+15,349$1,791,68970,173 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$75.93/sh+8,298$630,06720,408 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$100.05/sh+9,796$980,09030,204 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$94.00/sh+7,979$750,02638,183 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$97.15/sh+7,946$771,95454,824 total
  • Exercise/Conversion

    Common Stock

    2019-02-05$128.09/sh+9,386$1,202,25379,559 total
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-058,2980 total
    Exercise: $75.93Exp: 2021-02-09Common Stock (8,298 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-059,7960 total
    Exercise: $100.05Exp: 2022-02-08Common Stock (9,796 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-057,9790 total
    Exercise: $94.00Exp: 2023-02-13Common Stock (7,979 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-057910 total
    Exercise: $94.89Exp: 2024-02-12Common Stock (791 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-057,9462,648 total
    Exercise: $97.15Exp: 2025-03-16Common Stock (7,946 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-059,38628,152 total
    Exercise: $128.09Exp: 2027-03-08Common Stock (9,386 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-058,9620 total
    Exercise: $63.25Exp: 2020-02-10Common Stock (8,962 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-057,9040 total
    Exercise: $94.89Exp: 2024-02-12Common Stock (7,904 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2019-02-0515,34915,348 total
    Exercise: $116.73Exp: 2026-02-11Common Stock (15,349 underlying)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $178.00 to $179.39 per share. The price reported represents the weighted average sales price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
  • [F2]Options become exercisable in 25% increments on the first, second, third and fourth anniversary dates of the grant.

Documents

1 file

Issuer

MCDONALDS CORP

CIK 0000063908

Entity typeother

Related Parties

1
  • filerCIK 0001655026

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 3:07 PM ET
Size
34.9 KB